SCHEMBL3650021

SCHEMBL3650021

COC(=O)c1ccc(C(N)S(C)(=O)=O)cc1C(=O)O

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ HSD17B10 Q99714 8/20 0.46
▸ KMT2A Q03164 5/20 0.46
▸ TDP1 Q9NUW8 4/20 0.46
▸ MEN1 O00255 4/20 0.46
▸ CYP2C9 P11712 3/20 0.46
▸ CYP2C19 P33261 2/20 0.46
▸ CYP2D6 P10635 1/20 0.46
▸ GRM8 O00222 1/20 0.46
▸ GRM6 O15303 1/20 0.46
▸ SLC6A2 P23975 1/20 0.46
▸ SLC6A4 P31645 1/20 0.46
▸ DRD3 P35462 1/20 0.46
▸ GRM4 Q14833 1/20 0.46
▸ KDM4E B2RXH2 8/20 0.40
▸ SMN1; SMN2 Q16637 1/20 0.40
▸ ALDH1A1 P00352 9/20 0.39
▸ HPGD P15428 7/20 0.39
▸ GAA P10253 4/20 0.39
▸ MAPT P10636 3/20 0.39
▸ GLA P06280 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28458329 0.82 CA2 (0.54) HSD17B10KDM4ESMN1; SMN2ALDH1A1HPGD
SCHEMBL15754098 0.81 ACHE (0.44) HSD17B10KMT2ATDP1MEN1CYP2C9
SCHEMBL149826 0.79 KDM4E (0.49) HSD17B10KMT2ATDP1MEN1CYP2C9
SCHEMBL148325 0.79 SIRT6 (0.47) KMT2ATDP1MEN1KDM4ESMN1; SMN2
SCHEMBL8908076 0.79 HSD17B10 (0.46) HSD17B10KMT2ATDP1MEN1CYP2C9
SCHEMBL19066300 0.77 ALDH1A1 (0.43) HSD17B10KMT2ATDP1MEN1CYP2C9
SCHEMBL9269600 0.76 HSD17B10 (0.47) HSD17B10KMT2ATDP1MEN1CYP2C9
SCHEMBL3508966 0.74 KDM4E (0.40) HSD17B10TDP1KDM4ESMN1; SMN2ALDH1A1
SCHEMBL11575404 0.72 POLB (0.55) HSD17B10KMT2AMEN1KDM4ESMN1; SMN2
SCHEMBL9269604 0.72 HSD17B10 (0.46) HSD17B10KMT2ATDP1MEN1CYP2C9

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2205596-A1 (3-HYDROXY-4-AMINO-BUTAN-2-YL) -3- (2-THIAZOL-2-YL-PYRROLIDINE-1-CARBONYL) BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS BETA-SECRETASE INHIBITORS FOR TREATING COMENTIS, INC. (US) 2010-07-14 — — EP disclosed
WO-2009042694-A1 (3-HYDROXY-4-AMINO-BUTAN-2-YL) -3- (2-THIAZOL-2-YL-PYRROLIDINE-1-CARBONYL) BENZAMIDE DERIVATIVES AND RELATED COMPOUNDS AS BETA-SECRETASE INHIBITORS FOR TREATING COMENTIS, INC. (US) 2009-04-02 — — WO disclosed
Send feedback